Boston Scientific Closes NxThera Acquisition

MARLBOROUGH, Mass., April 30, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The company developed the Rezūm® system, a minimally invasive thera... Devices, Urology, Mergers & Acquisitions Boston Scientific, NxThera, Rezum system, benign prostatic hyperplasia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news